![Robustness of aerosol delivery of amikacin liposome inhalation suspension using the PARI eFlow® Technology - Medicine Robustness of aerosol delivery of amikacin liposome inhalation suspension using the PARI eFlow® Technology - Medicine](https://medicineinnovates.com/wp-content/uploads/2022/03/external-figure.jpg)
Robustness of aerosol delivery of amikacin liposome inhalation suspension using the PARI eFlow® Technology - Medicine
![In vitro efficiency of Amikacin Inhale, a novel drug-device delivery system | Critical Care | Full Text In vitro efficiency of Amikacin Inhale, a novel drug-device delivery system | Critical Care | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fcc12019/MediaObjects/13054_2013_Article_1176_Fig2_HTML.jpg)
In vitro efficiency of Amikacin Inhale, a novel drug-device delivery system | Critical Care | Full Text
![Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease - ScienceDirect Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0012369221002907-gr1.jpg)
Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease - ScienceDirect
![Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.00011-18/asset/1c3c0b88-5f94-4150-aaff-531f6da0c2b7/assets/graphic/zac0061872290001.jpeg)
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy
![Mean cumulative systemic absorption of amikacin as a function of time.... | Download Scientific Diagram Mean cumulative systemic absorption of amikacin as a function of time.... | Download Scientific Diagram](https://www.researchgate.net/profile/Stephan-Ehrmann/publication/5800487/figure/fig4/AS:277672988037128@1443213807809/Mean-cumulative-systemic-absorption-of-amikacin-as-a-function-of-time-Absorption-is_Q320.jpg)
Mean cumulative systemic absorption of amikacin as a function of time.... | Download Scientific Diagram
The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebul
![Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease | European Journal of Drug Metabolism and Pharmacokinetics Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease | European Journal of Drug Metabolism and Pharmacokinetics](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs13318-020-00669-7/MediaObjects/13318_2020_669_Fig2_HTML.png)
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease | European Journal of Drug Metabolism and Pharmacokinetics
![PDF) IN VITRO ASSESSMENT OF AEROSOLIZED AMIKACIN LUNG DOSE DELIVERED BY NKTR-061 PDDS CLINICAL DURING ON-VENTILATOR AND OFF-VENTILATOR USE PDF) IN VITRO ASSESSMENT OF AEROSOLIZED AMIKACIN LUNG DOSE DELIVERED BY NKTR-061 PDDS CLINICAL DURING ON-VENTILATOR AND OFF-VENTILATOR USE](https://www.researchgate.net/profile/Nani-Kadrichu/publication/278297310/figure/tbl1/AS:614002572947463@1523401029825/n-vitro-study-parameters-on-vent-and-handheld-configurations_Q320.jpg)
PDF) IN VITRO ASSESSMENT OF AEROSOLIZED AMIKACIN LUNG DOSE DELIVERED BY NKTR-061 PDDS CLINICAL DURING ON-VENTILATOR AND OFF-VENTILATOR USE
This handout provides distribution information for ARIKAYCE® (amikacin liposome inhalation suspension).
![Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00134-007-0935-1/MediaObjects/134_2007_935_Fig3_HTML.gif)
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
![Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1569199319308331-gr1.jpg)